Aktie A2P9RH ROSSARI BIOTECH LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Rossari Biotech Limited Bombay S.E.

Aktien

A2P9RH

INE02A801020

ROSSARI

Markt geschlossen - Bombay S.E.
Andere Börsenplätze
 12:00:49 26.04.2024 		% 5 Tage % 1. Jan.
769,8 INR +1,02 % Intraday Chart für Rossari Biotech Limited +6,79 % -3,67 %
06.04. Rossari Biotech Limited ernennt Sunil V mit Wirkung vom 15. April 2024 zum Chief Human Resource Officer CI
06.04. Rossari Biotech Limited genehmigt die Gründung einer hundertprozentigen Tochtergesellschaft in Dubai, Vereinigte Arabische Emirate CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Rossari Biotech Limited Appoints Sunil V as Chief Human Resource Officer, Effective April 15, 2024
Rossari Biotech Limited Approves Incorporation of Wholly Owned Subsidiary in Dubai, United Arab Emirates
Rossari Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Rossari Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
Rossari Biotech Limited Appoints Esha Padmanabhan Achan as Additional Director Designated as Non-Executive, Independent Director with Effective October 21, 2023
Rossari Biotech Incorporates Wholly-Owned Subsidiary in Bangladesh
Rossari Biotech Limited Announces Intimation of Incorporation of Rossari Bangladesh Limited, Wholly Owned Subsidiary
Rossari Biotech Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
Rossari Biotech Limited Announces Resignation of Melier Castelino as an Independent Director
Rossari Biotech Limited Appoints Ms. Aparna Sharma , as A Non-Executive, Independent Director, Effective 29Th April, 2023
Rossari Biotech Limited Declares Dividend for the Financial Year Ended 31 March, 2023
INDIA STOCKS-Indian shares open higher ahead of Fed rate decision
Rossari Biotech's Consolidated Profit Climbs in Fiscal Q4
Rossari Biotech Limited Reports Earnings Results for the Full Year Ended March 31, 2023
Rossari Biotech Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023
Rossari Biotech Limited Announces Management Changes
Rossari Biotech Limited Approves Final Dividend for the Financial Year Ended March 31, 2023
Rossari Biotech Completes Acquisition of 100% Stake in Tristar
Rossari Biotech Limited acquired Tristar Intermediates Private Limited.
Rossari Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2P9RH Aktie
  4. A2P9RH Aktie
  5. Nachrichten Rossari Biotech Limited
  6. Andere Sprachen